The Future of Drug Discovery

Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need in a more timely, cost effective and efficient manner than the current pharmaceutical industry approach.

Our business is targeted drug discovery, optimization and pre-clinical development using a rigorously developed series of computer models. Our approach allows us to discover and develop potential new therapies faster, cheaper and more efficiently than our competitors who still largely rely on traditional wet lab iterative methods. The benefits of our technology for our pharmaceutical and biotechnology partners include:

  • a faster time to market
  • increased profits for each successful new drug
  • an extension of useful patent life by an estimated 2 to 4 years and consequently greater drug sales revenue